New authorised medicine: GRASUSTEK (pegfilgrastim)

28 juin 2019

BlueRegWatch

GRASUSTEK is a medicine used in cancer patients to help with neutropenia which is a common side effect of cancer chemotherapy and can leave patients vulnerable to infections.
It is given specifically to reduce the duration of neutropenia and prevent febrile neutropenia.

BlueRegWatch

Vous avez aimé cet article ? Partagez le sur les réseaux sociaux :

Découvrez notre dernier livre blanc

En savoir plus